Betty C. Villafuerte
Medical Practice at Chestnut St, Louisville, KY
License number
Kentucky 37985
Issued Date
Jun 26, 2003
Expiration Date
Feb 28, 2018
Category
Endocrinology Diabetes & Metabolism
Type
Faculty
Address
Address
401 E Chestnut St #310, Louisville, KY 40202
Education
University of the Philippines Manila, 1981
Phone
(502) 588-4600 (Work)
Personal information
See more information about Betty C. Villafuerte at radaris.comName
Address
Phone
201 Abraham Flexner Way, Louisville, KY 40202
3611 Brownsboro Rd, Louisville, KY 40207
401 Chestnut St, Louisville, KY 40202
500 Jefferson St, Louisville, KY 40202
Organization information
See more information about Betty C. Villafuerte at bizstanding.comGastroenterology Hepatology - Betty C Villafuerte MD
401 E Chestnut St UNIT 310, Louisville, KY 40202
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Physicians & Surgeons
Phone:
(502) 588-6000 (Phone)
University Medical Associate PSC - Betty C Villafuerte MD
201 Abraham Flexner Way, Louisville, KY 40202
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Physicians & Surgeons
Phone:
(502) 589-6788 (Phone)
Professional information
Dr. Betty Villafuerte, Louisville KY - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
UofL Physicians - Endocrinology
401 E Chestnut St SUITE 310, Louisville 40202
(502) 588-6000 (Phone)
401 E Chestnut St SUITE 310, Louisville 40202
(502) 588-6000 (Phone)
Conditions:
Adrenal Disorders, Calcium Metabolism Disorders, Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, Endocrine System (Hormones)-Thyroid Disease, Hypoglycemia (Low Blood Sugar), Lipid Disorders, Metabolic Disorders, Ovarian Disorders, Pituitary Conditions, Reproductive Endocrinology, Testicle Disorders, Thyroid Disorders
Certifications:
Diabetes, Metabolism & Endocrinology, 2002, Internal Medicine, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UofL Physicians - Endocrinology
401 E Chestnut St SUITE 310, Louisville 40202
Jewish Hospital
200 Abraham Flexner Way, Louisville 40202
Norton Hospital
200 East Chestnut St, Louisville 40202
University of Louisville Hospital
530 South Jackson St, Louisville 40202
401 E Chestnut St SUITE 310, Louisville 40202
Jewish Hospital
200 Abraham Flexner Way, Louisville 40202
Norton Hospital
200 East Chestnut St, Louisville 40202
University of Louisville Hospital
530 South Jackson St, Louisville 40202
Philosophy:
At University of Louisville Physicians, we are committed to the delivering the very finest health care to our patients and their families and serving them with personalized care and compassion. As professors and researchers at the UofL School of Medicine, we offer our patients innovative technologies, state of the art treatments and the opportunity to be a part of world-renowned health care advancements.
Education:
Medical School
University Of The Philippines College Of Medicine
Graduated: 1981
Philippine General Hospital, Manila
Mercy Hospital Of Buffalo
Emory University Hospital
University Of The Philippines College Of Medicine
Graduated: 1981
Philippine General Hospital, Manila
Mercy Hospital Of Buffalo
Emory University Hospital
Betty Villafuerte, Louisville KY
Work:
University Medical Associates, PSC
401 E Chestnut St, Louisville, KY 40202 Robley Rex VA Medical Center
800 Zorn Ave, Louisville, KY 40206 Ambulatory Internal Medicine-Upa
550 S Jackson St, Louisville, KY 40202
401 E Chestnut St, Louisville, KY 40202 Robley Rex VA Medical Center
800 Zorn Ave, Louisville, KY 40206 Ambulatory Internal Medicine-Upa
550 S Jackson St, Louisville, KY 40202
Insulin-Responsive Dna Binding Proteins-1 And Methods To Regulate Insulin-Responsive Genes
US Patent:
7635766, Dec 22, 2009
Filed:
Jan 15, 2008
Appl. No.:
12/008962
Inventors:
Betty C. Villafuerte - Louisville KY, US
International Classification:
C07H 21/02, C07H 21/04
US Classification:
536 231, 536 241
Abstract:
The present invention relates to the novel protein Insulin-Responsive DNA Binding Protein-1 (IRDBP-1) and nucleotide sequences that encode it. IRDBP-1 binds to nucleic acid regions of genes that respond when cells are exposed to insulin. IRDBP-1 regulates genes important in mediating the insulin response in mammals and in regulating conditions such as diabetes, obesity, insulin-resistant syndrome and cell proliferative disorders. The present invention provides nucleic acids useful as probes for detecting nucleic acids encoding regions of the IRDBP-1 protein. Within the scope of the present invention are recombinant cells, tissues and animals containing non-naturally occurring recombinant nucleic acid molecules encoding IRDBP-1, including expression vectors, antibodies specific for IRDBP-1, assays for IRDBP-1 polypeptide, and methods relating to all of the foregoing, the development of therapeutic and diagnostic agents that mimic, facilitate or inhibit the action of IRDBP-1, and/or are based on relationships to the structure and action of IRDBP-1.
Transcript Factor And An Akt Substrate Related To Transcriptional Action Of Insulin And Applications Of Same
US Patent:
2006015, Jul 13, 2006
Filed:
Nov 29, 2005
Appl. No.:
11/288992
Inventors:
Betty Villafuerte - Louisville KY, US
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 38/18, C07K 14/475
US Classification:
514012000, 530399000
Abstract:
A transcription factor capable of activating multiple insulin-responsive genes. In one embodiment, the transcription factor includes an NH-domain containing thirteen epidermal growth factor (EGF)-like repeats proximate to the N-terminus, a solitary calcium-binding EGF-like domain proximate to the C-terminus, and three consecutive fibronectin type III (fn3) domains between the NH-domain and the EGF-like domain.